PMD - サイケメディクス (Psychemedics Corporation)

PMDのニュース

   Psychemedics GAAP EPS of -$0.29, revenue of $6.44M  2022/03/29 21:24:00 Seeking Alpha
Psychemedics press release (NASDAQ:PMD): Q4 GAAP EPS of -$0.29.Revenue of $6.44M (+20.6% Y/Y).
   Psychemedics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results  2022/03/29 21:15:00 GlobeNewswire
ACTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year financial results for the period ended December 31, 2021.
   Psychemedics (NASDAQ:PMD) Stock Price Passes Above 200-Day Moving Average of $0.00  2021/12/22 14:52:46 Dakota Financial News
Psychemedics Co. (NASDAQ:PMD) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $7.22. Psychemedics shares last traded at $7.22, with a volume of 5,375 shares traded. Separately, TheStreet upgraded shares of Psychemedics from a d+ rating to a []
   Psychemedics declares $0.05 dividend  2021/12/10 22:06:01 Seeking Alpha
   Psychemedics Corporation Declares Cash Dividend  2021/12/10 22:00:00 Intrado Digital Media
ACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the worlds largest provider of hair testing for drugs of abuse, today announced that it has declared a cash dividend of $0.05 per share to be paid on December 30 th , 2021 to shareholders of record as of December 20 th , 2021.
   Psychemedics GAAP EPS of -$0.29, revenue of $6.44M  2022/03/29 21:24:00 Seeking Alpha
Psychemedics press release (NASDAQ:PMD): Q4 GAAP EPS of -$0.29.Revenue of $6.44M (+20.6% Y/Y).
   Psychemedics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results  2022/03/29 21:15:00 GlobeNewswire
ACTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year financial results for the period ended December 31, 2021.
   Psychemedics (NASDAQ:PMD) Stock Price Passes Above 200-Day Moving Average of $0.00  2021/12/22 14:52:46 Dakota Financial News
Psychemedics Co. (NASDAQ:PMD) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $7.22. Psychemedics shares last traded at $7.22, with a volume of 5,375 shares traded. Separately, TheStreet upgraded shares of Psychemedics from a d+ rating to a []
   Psychemedics declares $0.05 dividend  2021/12/10 22:06:01 Seeking Alpha
   Psychemedics Corporation Declares Cash Dividend  2021/12/10 22:00:00 Intrado Digital Media
ACTON, Mass., Dec. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the worlds largest provider of hair testing for drugs of abuse, today announced that it has declared a cash dividend of $0.05 per share to be paid on December 30 th , 2021 to shareholders of record as of December 20 th , 2021.
   Psychemedics reports Q2 results  2021/08/10 21:18:28 Seeking Alpha
   Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results  2021/08/10 21:10:00 Intrado Digital Media
ACTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the worlds largest provider of hair testing for drugs of abuse, today announced financial results for the second quarter ended June 30, 2021.
   Global Drug of Abuse (DOA) Testing Equipment Market 2021 Future Set to Massive Growth with High CAGR value | Market Players: Siemens AG, Express Diagnostics Intl, Thermo Fisher Scientific, Merck, Quest Diagnostics, Roche, Abbott, Bio-Rad, Psychemedics  2021/07/23 23:10:56 Jumbo News
The report on Global Drug of Abuse (DOA) Testing Equipment Market has been provided by researchers for a detailed understanding of market performance over an estimated period of time set from 2021 to 2026. However, this report has introduced a brief overview to provide the reader with better information on this report. This brief description []
   Is Psychemedics Corp. (PMD) A Good Stock To Buy?  2021/06/14 20:25:49 Insider Monkey
   Montana Advisors Writes Open Letter to Psychemedics  2021/06/01 18:54:00 Business Wire
MIAMI--(BUSINESS WIRE)---- $PMD--Montana Advisors issues open letter to Psychemedics CEO (Nasdaq: PMD): Dear Kubacki: It was a pleasure speaking with you two months ago via Zoom. I appreciate the time you have given me to discuss Psychemedics Corp. (PMD or the Company). As you know, I continue to believe that PMD shares continue to trade at a significant discount to their intrinsic value. Montana has made recommendations on ways to unlock the value of the shares, including making your balance sheet wo

calendar